Nature Communications Publication Establishes Eyam’s Gemini™ as LNP-Free Biologics Platform, Stable Without Cold Chain

Eyam Health Inc. today announced the publication of peer-reviewed research in Nature Communications describing Gemini™, a ...
Le Lézard

Precision BioSciences Receives U.S. FDA Clearance of Investigational New Drug Application for First-in-Class PBGENE-DMD for Treatment of Duchenne Muscular Dy…

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to ...

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board

HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled upregulation of FAN1, a genetically validated ...

Solid Biosciences Inc. (SLDB) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 10:30 AM ESTCompany ParticipantsAlexander ...
Family Destinations Guide

This Down-Home Restaurant In Idaho Serves Up The Best Brisket You’ll Ever Taste

The Huckleberry Lemonade offers a taste of Idaho’s favorite berry in refreshing form – a perfect counterpoint to the rich, smoky flavors of the barbecue. One of the most endearing aspects of BBQ4LIFE ...

eXoZymes Advances Commercial Readiness With Profound Production Metrics From Initial NCT Pilot Run

The pilot run achieved approximately 99% reaction conversion, 90% isolated yield, and 535 grams of NCT at 99.6% ...

Neurogene Maps NGN-401 Pivotal Rett Timeline, Mid-2026 Data Update at Guggenheim Summit

Neurogene (NASDAQ:NGNE) is advancing a genetic medicines pipeline focused on rare neurologic diseases, with its lead program ...
AHA/ASA Journals

Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart ...

Risk prediction has been used in the primary prevention of cardiovascular disease for >3 decades. Contemporary cardiovascular risk assessment relies on multivariable models, which integrate ...